Skip to main content

Table 3 Multivariate analysis of platelet reactivity in patients under prasugrel

From: Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study

  Coefficient (SE) t 95 % CI Exponentiated coefficient* p-value
Male gender 0.07 (0.14) 0.25 −0.21 to 0.35 1.07 0.6
Current smoking 0.01 (0.16) 0.003 −0.31 to 0.33 1.01 0.9
-Insulin-treated diabetes mellitus (vs non-diabetic status) 0.42 (0.12) 12.0 0.18 to 0.65 1.52 0.001
-Non insulin-treated diabetes mellitus (vs non-diabetic status) 0.03 (0.11) 0.09 −0.19 to 0.25 1.03 0.8
Age 0.001 (0.004) 0.02 −0.007 to 0.008 1.001 0.9
Body mass index 0.02 (0.009) 3.35 −0.001 to 0.033 1.02 0.07
Creatinine clearance < 60 ml/min −0.07 (0.18) 0.15 −0.42 to 0.28 0.93 0.7
Statin −0.03 (0.38) 0.006 −0.77 to 0.71 0.97 0.9
Proton pump inhibitor 0.14 (0.19) 0.58 −0.22 to 0.50 1.15 0.4
Hypertension 0.07 (0.08) 0.88 −0.08 to 0.22 1.07 0.4
STEMI at admission −0.12 (0.08) 2.0 −0.27 to 0.04 0.89 0.2
  1. Abbreviations as in Table 2